The 1 Stock I'd Buy Before Berkshire Hathaway Right Now

Berkshire Hathaway faces near-term uncertainty after Warren Buffett's retirement at the end of 2025 and the appointment of Greg Abel as CEO, with the firm pausing buybacks for five quarters and underperforming the S&P 500 over the past year (BRK +6% vs S&P +16%), despite a 20-year gain of 756%. The author recommends Coca‑Cola as a more attractive holding: Berkshire owns 400 million KO shares (≈$31.2bn, 9.3% stake; 9.5% of Berkshire’s portfolio), Coca‑Cola forecasts 2025 organic revenue growth of 5%–6% (with 1–2 pts FX headwind), analysts project adjusted EPS +4% in 2025 and +8% in 2026, KO trades at ~24x forward earnings and yields ~2.6% with 63 consecutive years of dividend increases. The piece emphasizes Coca‑Cola’s capital‑light concentrate business and diversified beverage portfolio as defensive catalysts versus governance and valuation risks at Berkshire.

Analysis

Market structure: Buffett’s exit and Berkshire’s buyback pause reprice a conglomerate discount — beneficiaries are large, liquid consumer staples (KO, PEP) and fixed-income safe-havens as risk-premia rise; losers are BRK.A/BRK.B shareholders and active value funds that relied on Buffett’s deal flow. Coca‑Cola’s capital‑light concentrate model (24x forward P/E, 2.6% yield) increases pricing power and cash conversion versus capital‑intensive insurers/railroads, and Berkshire’s 400M‑share KO stake (≈$31.2B) creates a durable strategic anchor for KO liquidity.

Risk assessment: Near term (days–weeks) expect elevated BRK volatility on sentiment and potential block trade rumors; short term (3–12 months) key risks are management execution at BRK and FX headwinds trimming KO organic growth by 1–2ppt as warned. Tail risks include a governance misstep at BRK triggering a >25% rerating, or a material KO input‑cost shock (sugar/fuel) compressing margins >200bps; hidden dependency: KO’s bottler network can amplify supply disruptions regionally.

Trade implications: Direct: overweight KO vs underweight BRK.B — establish positions within 2 weeks and horizon 6–18 months to capture buyback clarity or KO steady growth. Options: buy KO 18–36m LEAP calls (30‑delta) funded by selling 2–3m OTM BRK.B calls to exploit higher BRK IV; target portfolio exposure to KO at 2–4% notional. Sector: rotate modestly from insurers/industrials into consumer staples and 2–5y Treasuries until Berkshire’s capital allocation stance clarifies.

Contrarian angles: Consensus underweights BRK’s embedded liquid assets and undervalues the option that new management maintains capital discipline — a resumed buyback could force a sharp BRK rebound; conversely, consensus underestimates the short‑term execution tailwind for KO as consumers trade down to value SKUs. Historical parallels: founder succession shocks (e.g., Ford, 2006) often overshoot then mean‑revert within 9–18 months. Unintended consequence: an opportunistic BRK liquidation of KO could create a transient KO price gap of 8–15% — hedge pair trades accordingly.

Key Decisions for Investors

• Establish a 2–3% portfolio long in KO within 2 weeks (ticker KO), horizon 12–18 months; set a stop‑loss at 10% and trim to take profits at +25–30% or if KO organic revenue guidance misses by >200bps.
• Implement a dollar‑neutral pair: long $100k KO vs short $60k BRK.B (tickers KO / BRK.B) over 6–12 months to capture relative resilience; rebalance if BRK signals resumed buybacks or if KO EPS revisions fall >5% consensus.
• Buy KO 18–36 month LEAP calls (~30‑delta) sized to 0.5–1.5% of portfolio and fund by selling 2–3 month OTM BRK.B calls (collect premium) to exploit elevated BRK IV; cap net option exposure to 1% portfolio risk.
• Trim direct BRK exposure by ~50% over next 30 days (if >2% portfolio) and reallocate proceeds to KO and 2–5y USTs until Berkshire’s post‑Buffett capital allocation clarity (expected within 6 months) is achieved.